Total raised
—
Last: Pre-Seed 2024-12
Stage
Pre-Seed
Founded
2024
Headcount
5
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
At Cellyrix, we are on a mission to introduce a new modality into cancer treatment by harnessing the power of cutting-edge technologies. Tumor heterogeneity, a fundamental aspect of cancer, lies at the heart of treatment challenges such as therapy resistance, metastasis, and relapse. Leveraging breakthroughs in single-cell sequencing and artificial intelligence, we are pioneering a novel approach to unlock insights into intra-tumor heterogeneity and develop innovative cancer treatments.
Funding history · 1 round · — total
2024-12
Pre-Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Cellyrix Therapeutics founded?
- Cellyrix Therapeutics was founded in December 2024.
- What is Cellyrix Therapeutics' primary focus?
- Cellyrix Therapeutics focuses on introducing a new modality into cancer treatment by addressing tumor heterogeneity, leveraging single-cell sequencing and artificial intelligence.
- Where is Cellyrix Therapeutics headquartered?
- Cellyrix Therapeutics is headquartered in Rehovot, Israel.
- What is the current employee count for Cellyrix Therapeutics?
- Cellyrix Therapeutics currently has 5 employees.
- Which sector does Cellyrix Therapeutics primarily operate in?
- Cellyrix Therapeutics' primary sector is Health Tech & Life Sciences.
- What was Cellyrix Therapeutics' first funding round?
- Cellyrix Therapeutics secured a Pre-Seed funding round in December 2024, with AION Labs as a lead investor.
- Who are the founders of Cellyrix Therapeutics?
- The founders of Cellyrix Therapeutics are Eran Kotler, Avishai Gavish, Mordechai Applebaum, and Dganit Bar.
- What technologies does Cellyrix Therapeutics utilize in its approach?
- Cellyrix Therapeutics utilizes Biologicals, Molecules, and Artificial Intelligence in its approach to cancer treatment.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMoleculesArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
drug-discoverycancer-therapypharmaceuticalsdrug-developmentcancerbiotechnologyartificial-intelligence